Systematic Reviewmoderate evidence

Heterogeneity of Treatment Effect by Molecular Endotype in Acute Respiratory Distress Syndrome: A Systematic Review.

Annals of the American Thoracic Society·September 12, 2026·PMID 42730647

Why it matters

ARDS trials have largely failed to identify effective therapies, possibly due to biological heterogeneity. This review clarifies which endotype-based subgroup effects are credible, helping critical care clinicians interpret post-hoc analyses and prioritize which endotype-guided approaches warrant prospective validation.

Infographic summary of Heterogeneity of Treatment Effect by Molecular Endotype in Acute Respiratory Distress Syndrome: A Systematic Review.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled